Chronic Heart Failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >= 60 years; 2. Clinically diagnosed with chronic heart failure, in accordance with the diagnostic criteria specified in the 2023 European Society of Cardiology (ESC) Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure, with cardiac function classified as NYHA Class I–III; 3. Voluntarily participated in this study and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Complicated with severe cardiovascular diseases or presenting with the following conditions: early stage of acute coronary syndrome, acute arrhythmia, high-grade atrioventricular block, acute myocarditis, infective endocarditis, new-onset atrial fibrillation, acute heart failure, severe aortic stenosis, obstructive hypertrophic cardiomyopathy, intracardiac thrombus, unstable angina or myocardial infarction within 3 months, cardiac arrest within 6 months, peripartum cardiomyopathy within 6 months, severe chronic obstructive pulmonary disease, poorly controlled blood pressure (systolic blood pressure >= 180 mm Hg or diastolic blood pressure >= 100 mm Hg), or resting heart rate > 120 beats per minute; 2. Complicated with metabolic diseases such as acute thyroiditis, hypokalemia, hyperkalemia, etc.; 3. Implanted with devices such as implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy (CRT); 4. Others: valvular heart disease requiring surgery, or patients scheduled for heart transplantation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| short physical performance battery, SPPB; | — |
Secondary
| Measure | Time frame |
|---|---|
| 6-minute walk distance,6MWD;Minnesota Living with Heart Failure Questionnaire,MLHFQ);Pittsburgh Sleep Quality Index, PSQI;Montreal Cognitive Assessment, MoCA; | — |
Countries
China
Contacts
The First Affiliated Hospital of Dalian Medical University